DCM
ELAN icon

Defilade Capital Management’s Elanco Animal Health ELAN Stock Holding History

Defilade Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3M Sell
864,080
-67,041
-7% -$1.55M 2.85% 15
2026
Q1 		$22.3M Buy
931,121
+529,838
+132% +$13M 3.13% 15
2025
Q4 		$9.08M Buy
+401,283
New +$8.73M 1.23% 27

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Defilade Capital Management's ELAN Position: Q2 2026 in Review

Defilade Capital Management reduced its Elanco Animal Health (ELAN) stake by 7.2% in Q2 2026, selling an estimated $1.55M and leaving 864,080 shares worth $21.3M. The position accounts for 2.85% of the portfolio, ranked #15.

Defilade Capital Management first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.3M in Q1 2026. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Defilade Capital Management held 864,080 shares of Elanco Animal Health worth $21.3M as of Q2 2026.
  • Defilade Capital Management sold 67,041 Elanco Animal Health shares in Q2 2026, an estimated $1.55M.
  • Elanco Animal Health made up 2.85% of Defilade Capital Management's portfolio in Q2 2026, its #15 holding.
  • Defilade Capital Management first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Defilade Capital Management's Elanco Animal Health position peaked at $22.3M in Q1 2026.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Defilade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.